Adtalem Q1 revenue $354.6M (+22.7%); adjusted EPS $0.88 (+151%); margins expand

Covista Inc.

2023-Q1 EPS reported $0.05 revenue$354,559,000

Revenue $354.6M up 22.7% YoY; diluted EPS $0.05 vs loss of $1.17; adjusted EPS $0.88 up 151.4%.
Adjusted operating income $65.1M up 78.7%; adjusted EBITDA $82.1M up 62.6%; margin expanded to 23.1% from 17.5%.
Gross debt reduced by $101M (11.7%) in Q1.
Segment: Chamberlain revenue flat, enrollment -4%; Walden enrollment -9.2%; Medical/Vet enrollment +3.4%.
Reaffirmed FY2023 guidance: revenue $1,380M-$1,450M, adjusted EPS $3.95-$4.20.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Covista Inc. reported first quarter fiscal 2023 ended Sept. 30, 2022 results: revenue $354.6 million, net income $2.2 million, EPS $0.05. Guidance reaffirmed.

Period: first quarter fiscal 2023 ended Sept. 30, 2022
Revenue: $354.6 million
Net income: $2.2 million
EPS: $0.05
Guidance: reaffirmed
Result: reported results

Exact text from the filing

healthcare professionals while driving superior student outcomes. ” Financial Highlights Selected financial data for the three months ended Sept. 30, 2022: ● Revenue of $354.6 million increased 22.7% compared with the prior year due to the timing of the acquisition of Walden ● Diluted earnings per share increased to $0.05 from a loss of $1.17 in the prior

View on SEC.gov

Browse all earnings releases →

Covista Inc. filing history →

Source: SEC EDGAR

accession 0001157523-22-001521

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.